Actively Recruiting
Clinical Study of the Anthelia Intense Pulsed Light Device for Treating Skin Conditions Including Excessive Hairiness, Vascular and Pigmented Lesions, and Acne Vulgaris
Led by Eurofeedback · Updated on 2024-10-23
85
Participants Needed
5
Research Sites
48 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the Anthelia Intense Pulsed Light IPL medical device for treating various skin conditions including excessive hairiness, vascular lesions, pigmented lesions, and acne vulgaris. The study is a post-market clinical trial conducted to assess the devices effectiveness and safety in these skin disorders. The IPL device has been FDA-cleared since 1995 and is noted for its cost-effectiveness and versatility compared to single-spectrum lasers. Participants will receive treatment with the Anthelia IPL device during multiple visits, following the devices instructions for use. The treatments target unwanted hair, varicosities, rosacea, solar lentigines, and facial acne, with specific inclusion criteria for skin types and condition characteristics. The study includes follow-up periods ranging up to 18 months to evaluate treatment effects. During the study, participants will undergo assessments to measure effectiveness using scores such as IRBMS, DLQI, and ECLA for acne patients. Safety and treatment response will be monitored over periods from 4 to 18 months depending on the condition treated. Participants will be evaluated regularly to track improvements in hairiness, vascular and pigmented lesions, and acne, ensuring comprehensive monitoring throughout the trial.
CONDITIONS
Brief Title
Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder
Research Team
L
Laurent Zawadil
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here